Trial intelligence / Profile preview

Oliceridine vs fentanyl anesthesia for transurethral lithotomy recovery

ChiCTR2600127824Phase 4Recruiting

Sponsor
Jiangmen Central Hospital
Start
Jul 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of oliceridine in ureterolithiasis, cystolithiasis, urethral calculus and 4 more (2 arms), sponsored by Jiangmen Central Hospital. Primary endpoint: Quality of recovery on the first postoperative day (QoR-15). Started Jul 2026; status: recruiting.

02

Drugs

oliceridine
03

Conditions

ureterolithiasiscystolithiasisurethral calculuspostoperative painPerioperative cardiovascular instability (PCVI)

Beyond the preview

Go deeper on ChiCTR2600127824.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600127824.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call